Coronavirus India LIVE Updates, Coronavirus Cases Today, COVID 19 Cases In India, Omicron Covid Cases, India Covid Cases 25 April 2022

[ad_1]

As the fear of getting fined for not wearing masks set in after the DDMA order, people in the national capital have again started masking up in public places, especially at busy markets, railway stations, Metro, buses and ISBTs. The inspection by the Delhi Police and authorities at these places has also intensified again. Delhi Friday reported 1,042 fresh Covid cases with a positivity rate of 4.64 per cent while two persons died due to the infection, according to data shared by the city health department on Friday.

Meanwhile, Maharashtra Deputy Chief Minister Ajit Pawar on Friday cited rising Covid-19 cases in Delhi and said people can continue wearing masks like him voluntarily though the state government had now made it optional. In Chennai, Tamil Nadu Health Secretary J Radhakrishnan said that people who fail to wear masks in public places will be penalised Rs 500 and the district collectors have been asked to monitor them.

A common anti-inflammatory drug has been found to be an effective antiviral agent in the treatment of mild and moderate Covid-19 patients. The drug, indomethacin, is widely used to treat various types of inflammation-related conditions. The study on Covid patients, by IIT Madras, has been published in Nature Scientific Reports.

THE DRUG: Indomethacin is a non-steroidal anti-inflammatory drug available as capsules and a liquid suspension, to be taken orally. According to the US National Library of Medicine, indomethacin works by stopping the body’s production of a substance that causes pain, fever, and inflammation. It is used to relieve moderate to severe pain, tenderness, swelling, and stiffness caused by various kinds of arthritis, and pain in the shoulder caused by inflammation.

The findings: A randomised clinical trial was conducted by IIT Madras researchers at Panimalar Medical College and Research Institute, Chennai. Out of 210 patients admitted, 107 were randomly allocated to a control group and treated with paracetamol and standard care, while 103 patients were administered indomethacin along with standard care of treatment, a media release from IIT Madras said.
EXPLAINED | Common drug found effective against mild & moderate Covid

A UK patient with a severely weakened immune system had Covid-19 for almost a year and a half, scientists reported, underscoring the importance of protecting vulnerable people from the coronavirus. There’s no way to know for sure whether it was the longest-lasting Covid-19 infection because not everyone gets tested, especially on a regular basis like this case.

But at 505 days, “it certainly seems to be the longest reported infection,” said Dr. Luke Blagdon Snell, an infectious disease expert at the Guy’s and St. Thomas’ NHS Foundation Trust.



[ad_2]